Skip to main content

Table 2 In-patient mortality by concomitant interstitial lung disease and demographic factors

From: Influence of interstitial lung disease on systemic sclerosis hospitalizations, a national study (2002–2020)

 

Unadjusted

Adjusted

ILD: Yes

ILD: No

Ratio (95% CI)

p

Ratio (95% CI)

p

In-patient mortality, %

12.11

6.38

1.90 (1.55–2.32)

< 0.001

1.88 (1.53–2.31)

< 0.001

By age

Varied, see Fig. 1

0.021

Varied, see Fig. 1

0.021

By biological sex

   

0.087

 

0.128

 Female

13.32

5.94

2.07 (1.65–2.61)

< 0.001

2.05 (1.62–2.59)

< 0.001

 Male

11.42

8.34

1.37 (0.90–2.08)

0.141

1.41 (0.93–2.15)

0.108

By race

   

0.218

 

0.222

 White

14.01

7.20

2.15 (1.68–2.76)

< 0.001

2.10 (1.64–2.70)

< 0.001

 Black

8.65

8.10

1.30 (0.85–1.98)

0.232

1.27 (0.82–1.95)

0.279

 Hispanic

10.35

6.91

2.18 (1.19–4.01)

0.012

2.21 (1.20–4.08)

0.011

 Other

14.13

10.97

1.89 (0.79–4.39)

0.152

1.83 (0.77–4.34)

0.169

Income quartile

   

0.569

 

0.581

 I

11.36

6.69

1.70 (1.16–2.48)

0.006

1.69 (1.16–2.48)

0.007

 II

12.28

5.24

2.34 (1.52–3.61)

< 0.001

2.31 (1.49–3.58)

< 0.001

 III

12.39

5.94

2.09 (1.37–3.17)

0.001

2.10 (1.38–3.20)

< 0.001

 IV

12.49

7.50

1.66 (1.17–2.37)

0.005

1.65 (1.15–2.35)

0.006

By facility type

   

0.557

 

0.524

 Rural

7.48

6.42

1.17 (0.45–3.04)

0.754

1.11 (0.42–2.93)

0.830

 Urban nonteaching

14.31

7.78

1.84 (1.28–2.64)

0.001

1.83 (1.27–2.63)

0.001

 Urban teaching

11.74

5.88

1.99(1.55–2.57)

< 0.001

1.97 (1.53–2.55)

< 0.001

  1. The table presents the In-patient mortality percentage of patients with systemic sclerosis with and without ILD. The table contains both the unadjusted and adjusted odds of In-patient mortality by ILD status. The unadjusted data includes the raw results and direct relationship between variables without control for confounding factors. The adjusted data is statistically modified to control for possible confounding factors including age, sex, race, ect. A p value < 0.05 indicates a significant difference between In-patient mortality % by the respective demographic factor
Back to article page

Advances in Rheumatology

ISSN: 2523-3106